Evidence map›Paper›PMID 33264655›Full record

ArticleExperimental eye research2021

An efficient inducible RPE-Selective cre transgenic mouse line.

Ming Chen, Lily Kim, Carolyn W Lu, Hong Zeng, Douglas Vollrath

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Alternative oxidase blunts pseudohypoxia and photoreceptor degeneration due to RPE mitochondrial dysfunction.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Retinal Development and Pathophysiology in Kcnj13 Knockout Mice.Frontiers in cell and developmental biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ming ChenDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, United States.
Lily KimDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, United States.
Carolyn W LuDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, United States.
Hong ZengTransgenic, Knockout, and Tumor Model Center, Stanford University School of Medicine, Stanford, CA, 94305, United States.
Douglas VollrathDepartment of Genetics, Stanford University School of Medicine, Stanford, CA, 94305, United States. Electronic address: vollrath@stanford.edu.
Stanford University · US

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
RPE Energy Metabolism and Cell PhenotypeR01EY025790 · NEI · STANFORD UNIVERSITY · PI VOLLRATH, DOUGLAS E. · 2016 to 2021
$2.4M
NEI NIH HHS P30 EY026877NEI NIH HHS R01 EY025790
6 · The paper itself

Abstract

Cre-mediated modulation of gene function in the murine retinal pigment epithelium (RPE) has been widely used, but current postnatal RPE-selective Cre driver lines suffer from limited recombination efficiency and/or ectopic or mosaic expression. We sought to generate a transgenic mouse line with consistently efficient RPE-selective Cre activity that could be temporally regulated. We used ϕC31 integrase to insert a DNA construct encoding a human BEST1 promoter fragment driving a Cre recombinase estrogen receptor fusion (BEST1-CreERT2) at the Rosa26 locus of C57BL/6J mice. Rosa26

Indexed as

Gene Expression RegulationAnimalsDisease Models, AnimalElectroretinographyIntegrasesMacular DegenerationMiceMice, Inbred C57BLMice, TransgenicRetinal Pigment EpitheliumRNATomography, Optical CoherenceCre recombinaseIntegrasesRNACre recombinaseInducible expressionRetinal pigment epitheliumTamoxifentdTomato

Identifiers

PMID33264655
PMCPMC7856207
OpenAlexW3110240282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.